Connect with us

Business

Medical Cannabis by Shoppers Inc And UHN Selects Medipharm Labs Corp (OTCMKTS:MEDIF) For Tracking Medical Cannabis Products

Published

on

Medical Cannabis by Shoppers Inc (MCS) and UHN (University Health Network) selected Medipharm Labs Corp (OTCMKTS:MEDIF) to track the medical-use cannabis products using blockchain technology.

VP (Business Development and Cannabis Strategy) of Shoppers Drug Mart, Ken Weisbord, said MCS is excited to enter into a pact with a trusted name in the cannabis industry – Medipharm for this groundbreaking research project. MCS already has a proven commercial relationship with Medipharm. He further said the success of this R & D project will depend on collaboration with Shoppers on board, TruTrace Technologies Inc (OTCMKTS:TTTSF), Medipharm, and UHN.

Integrates secured software platform with MCS portal

TruTrace developed a secured software platform using blockchain technology and integrated with the portal of MCS to manage, track, and locate the medical cannabis strains in 7 unique products of Medipharm. The platform will track extracts and oils of Medipharm in each step in the supply chain.

CEO of TruTrace, Robert Galarza, said the cannabis industry for medicinal use has been evolving over the past few years. Medipharm put in significant effort during this course to produce high-quality products using industry-standard protocols and GMP standards. It also yearns to lead innovation by collaborating with leaders like TruTrace to drive growth going forward. Robert said TruTrace will play an important role in exploring the power of transparent and dynamic data to support the initiatives of Medipharm in Canada and overseas.

Pat McCutcheon, CEO of Medipharm, said it is an important trial conducted by leading and biggest research organizations in Canada. The company will reap the benefits of new technology to offer cannabis products for medical patients.

GMP certified products

Medipharm is committed to providing high-quality cannabis products complying with GMP standards. They are rigorously tested before reaching the customers. This study provides confidence to the physicians and provides transparency on products to the customers. It offers details of the products like effectiveness, composition, and product chemistry. Therefore, physicians can prescribe tested and validated products in a precise dose to their patients.

Enters a supply pact with Hybrid Pharm Inc

Medipharm inked a supply agreement with Hybrid Pharm Inc. As per the terms of the deal, Medipharm will supply medicinal cannabis products to Hybrid Pharm, a renowned pharmacy in Canada.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.